News & Analysis as of

Public Health › New Guidance › Regulatory Oversight

Hogan Lovells

FDA Commissioner’s National Priority Voucher program comes with questions surrounding implementation

Hogan Lovells on

The U.S. Food and Drug Administration (FDA) announced Tuesday a “Commissioner’s National Priority Voucher” (CNPV) program, which will provide a “limited number” of vouchers to sponsors of drug products that are “aligned with...more

Holland & Knight LLP

Hopefully EPA Will Soon Pass Judgment on New Technologies to Destroy PFAS

Holland & Knight LLP on

On April 28, 2025, the U.S. Environmental Protection Agency (EPA) announced "major EPA actions to combat PFAS contamination." EPA Administrator Lee Zeldin said that he has "long been concerned about PFAS and the efforts to...more

Nossaman LLP

EPA Report: Coronavirus and Drinking Water and Wastewater

Nossaman LLP on

This week, the Environmental Protection Agency (EPA) released guidance on the coronavirus and the U.S. drinking and waste water systems.  According to the EPA, “Based on current evidence, the risk to water supplies is low. ...more

Epstein Becker & Green

After Decades of Broad Enforcement Discretion, FDA Signals New Approach to Homeopathic Drugs

Epstein Becker & Green on

Two announcements made by FDA in late October signal a marked change to FDA’s regulatory approach to “homeopathic” drugs. On October 25, 2019, FDA withdrew the 1988 Compliance Policy Guide (“CPG”) 400.400 Conditions Under...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide